Roth Capital Keeps $5 Price Target on 22nd Century Group (XXII): 'Full Steam Ahead with FDA Menthol Ban'
Tweet Send to a Friend
Roth Capital analyst Brian Wright reiterated a Buy rating and $5.00 price target on 22nd Century Group (NASDAQ: XXII)The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
